News

01/01/70
STALLERGENES to present at the 33rd annual J.P. MORGAN healthcare conference on January 15, 2015

 

 

Antony, France, 18 December 2014 – STALLERGENES S.A. (Euronext Paris),...

[more]
20/11/14
STALLERGENES and ACTOGENIX to develop an innovative new class of oral allergy treatments

 

Stallergenes exercised option to pursue the exclusive development...

[more]

Follow us on :

STALLERGENES, A GLOBAL ALLERGY PLAYER


Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world. 

Stallergenes’ comprehensive approach to allergic diseases includes a complete portfolio combining diagnosis products and treatments and a new generation of allergen immunotherapy treatments.